false
Catalog
Using Telepsychiatry for Serious Mental Illness: A ...
Presentation Slides
Presentation Slides
Back to course
Pdf Summary
The document is an introduction to using telepsychiatry for serious mental illness, presented as part of the Clinical Support System for Serious Mental Illness (CSS-SMI) initiative by the American Psychiatric Association (APA) and the Substance Abuse and Mental Health Services Administration (SAMHSA). Telepsychiatry, a form of telemedicine, involves providing mental health services remotely using technology such as videoconferencing. It can include psychiatric evaluations, therapy, patient education, and medication management. The document provides information on the benefits and limitations of telepsychiatry, including improved access to care, integration of behavioral health and primary care, reduced delays in care, and reduced barriers such as transportation and stigma. <br /><br />The document discusses various types of telepsychiatry, including live videoconferencing, store and forward transmission, remote patient monitoring, and mobile health. It also addresses practical considerations such as licensure, malpractice coverage, state and federal regulations, and reimbursement. Best practices for telepsychiatry are outlined, including conducting thorough assessments, ensuring patient safety, maintaining rapport and therapeutic alliance with patients, and addressing ethical and cultural considerations. The document includes references to additional resources and research on telepsychiatry and its effectiveness for patients with serious mental illness.<br /><br />Overall, the document provides an overview of the use of telepsychiatry for serious mental illness, highlighting its potential benefits and practical considerations for implementation.
Keywords
telepsychiatry
serious mental illness
Clinical Support System for Serious Mental Illness
videoconferencing
access to care
integration of behavioral health and primary care
practical considerations
best practices for telepsychiatry
patient safety
effectiveness of telepsychiatry
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
×
Please select your language
1
English